Oncolytics Biotech Inc Cash Flow Reinvestment Rate
Latest as of June 2018:
0.06x
Oncolytics Biotech Inc cash flow reinvestment rate. Oncolytics Biotech Inc (ONC) has a Cash Flow Reinvestment Rate of 0.06x as of June 2018, reinvesting CA$37.44K (capex CA$37.44K ) from operating cash flow of CA$589.26K. Explore how well can Oncolytics Biotech Inc service its debt to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
0.06x
(Capex + Investments) / Operating CF
Total Reinvested
CA$37.44K
Capex + Investments
Operating Cash Flow
CA$589.26K
CAD
Capital Expenditures
CA$37.44K
CAD
Oncolytics Biotech Inc Cash Flow Reinvestment Rate by Year (None–None)
Oncolytics Biotech Inc cash flow reinvestment rate by year from None to None. Year-by-year capital reinvestment analysis for Oncolytics Biotech Inc. For the full cash flow conversion analysis, see ONC cash flow metrics.
| Year | Reinvestment Rate | Total Reinvested (CAD) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow